Get the Stockscreener App
16.70
1.07%
-0.18
After Hours:
16.70
Eton Pharmaceuticals Inc stock is traded at $16.70, with a volume of 279.67K.
It is down -1.07% in the last 24 hours and down -4.35% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$16.88
Open:
$17.02
24h Volume:
279.67K
Relative Volume:
0.93
Market Cap:
$447.85M
Revenue:
$31.38M
Net Income/Loss:
$-6.69M
P/E Ratio:
-64.23
EPS:
-0.26
Net Cash Flow:
$-1.84M
1W Performance:
+2.71%
1M Performance:
-4.35%
6M Performance:
+15.09%
1Y Performance:
+37.34%
1-Day Range:
$16.65
$17.19
1-Week Range:
$16.13
$17.19
52-Week Range:
$11.09
$23.00
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
16.70 | 452.68M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
FY2025 EPS Estimate for Eton Pharmaceuticals Cut by Analyst - Defense World
What is HC Wainwright's Estimate for ETON FY2025 Earnings? - MarketBeat
Is Now The Right Time To Take A Closer Look At Eton Pharmaceuticals? - RTTNews
HC Wainwright Issues Negative Forecast for ETON Earnings - Defense World
Q4 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst - MarketBeat
Divisadero Street Capital Management LP Purchases New Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
With Eton Pharmaceuticals Stock Sliding, Have You Assessed The Risk? - Trefis
Geode Capital Management LLC Has $8.45 Million Stock Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Diametric Capital LP Increases Stock Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Will Eton Pharmaceuticals Inc. stock continue dividend increasesWeekly Stock Report & Weekly Breakout Opportunity Watchlist - Newser
Implied Volatility Surging for Eton Pharmaceuticals Stock Options - sharewise.com
Why Eton Pharmaceuticals Inc. stock is in analyst buy zoneEarnings Risk Report & Risk Controlled Swing Trade Alerts - Newser
Eton Pharmaceuticals Joins Piper Sandler Healthcare Conference - TipRanks
(ETON) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Is Eton Pharmaceuticals Inc. stock a safe buy before earningsTrade Volume Report & Weekly Market Pulse Updates - Newser
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives $29.67 Average PT from Analysts - Defense World
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Aristides Capital LLC Has $2.39 Million Stock Holdings in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Is Eton Pharmaceuticals Inc. stock a buy on dipsPortfolio Update Summary & Weekly Sector Rotation Insights - moha.gov.vn
Eton acquires Wilson disease drug Galzin - MSN
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th - The Manila Times
(ETON) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Is Eton Pharmaceuticals Inc. stock positioned for digital transformationMarket Activity Report & AI Forecast for Swing Trade Picks - newser.com
Why Eton Pharmaceuticals Inc. stock is favored by top institutions2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Can Eton Pharmaceuticals Inc. stock hit record highs againJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Is Eton Pharmaceuticals Inc. stock trading near support levelsJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
[S-8] Eton Pharmaceuticals, Inc. Employee Benefit Plan Registration | ETON SEC FilingForm S-8 - Stock Titan
Is Eton Pharmaceuticals Inc. stock bottoming outPortfolio Gains Summary & Real-Time Market Trend Scan - newser.com
Using RSI to spot recovery in Eton Pharmaceuticals Inc.Dividend Hike & Daily Volume Surge Trade Alerts - newser.com
[8-K/A] Eton Pharmaceuticals, Inc. Amends Material Event Report | ETON SEC FilingForm 8-K/A - Stock Titan
Eton Pharmaceuticals (NASDAQ:ETON) Stock Rating Lowered by Zacks Research - MarketBeat
Will Eton Pharmaceuticals Inc. stock see insider buyingAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - newser.com
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Share Price Matching Investor Opinion - simplywall.st
Institutional Investors in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Lost 12% Last Week but Have Reaped the Benefits of Longer-term Growth - 富途牛牛
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th - The Manila Times
Eton Pharmaceuticals (NASDAQ: ETON) to Attend 16th Craig-Hallum Alpha Select Nov. 18 - Stock Titan
Liquidity Mapping Around (ETON) Price Events - news.stocktradersdaily.com
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):